Skip to main content

Total Knee Arthroplasty clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • Dexamethasone in Total Knee Arthroplasty

    open to eligible people ages 18 years and up

    The purpose of this study is to determine the most efficacious and safest dexamethasone dose given intraoperatively during total knee arthroplasty that reduces postoperative opioid consumption and pain, improves postoperative nausea and vomiting, and minimizes postoperative complications.

    San Francisco, California and other locations

Our lead scientists for Total Knee Arthroplasty medical studies include .

Last updated: